| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Jun 18, 2026 | Option/RSU Exercise | $5.35 | 10,000 | 53,500 | 114,395 | Jun 18, 2026, 08:07 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Jun 18, 2026 | Sale | $53.00 | 10,000 | 530,000 | 104,395 | Jun 18, 2026, 08:07 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Mar 09, 2026 | Tax Payment (Shares) | $59.32 | 1,021 | 60,566 | 104,395 | Mar 11, 2026, 05:24 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Feb 28, 2026 | Tax Payment (Shares) | $61.98 | 898 | 55,658 | 106,425 | Mar 02, 2026, 08:08 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Mar 02, 2026 | Tax Payment (Shares) | $61.98 | 1,009 | 62,538 | 105,416 | Mar 02, 2026, 08:08 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Jan 14, 2026 | Gift | - | 61,850 | - | 62,459 | Jan 16, 2026, 05:09 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Jan 14, 2026 | Gift | - | 61,850 | - | 61,850 | Jan 16, 2026, 05:09 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Sep 08, 2025 | Tax Payment (Shares) | $32.41 | 2,890 | 93,665 | 124,309 | Sep 10, 2025, 04:26 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Sep 02, 2025 | Tax Payment (Shares) | $31.56 | 5,080 | 160,325 | 131,009 | Sep 04, 2025, 04:10 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Apr 07, 2025 | Option/RSU Exercise | $20.93 | 4,777 | 99,983 | 131,950 | Apr 09, 2025, 08:05 AM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Feb 28, 2025 | Tax Payment (Shares) | $73.02 | 1,270 | 92,735 | 130,982 | Mar 03, 2025, 09:32 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Mar 03, 2025 | Tax Payment (Shares) | $72.10 | 3,809 | 274,629 | 127,173 | Mar 03, 2025, 09:32 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Feb 18, 2025 | Option/RSU Exercise | $5.35 | 8,000 | 42,800 | 117,491 | Feb 19, 2025, 06:04 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Feb 18, 2025 | Sale | $83.85 | 8,000 | 670,823 | 111,309 | Feb 19, 2025, 06:04 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Jan 21, 2025 | Option/RSU Exercise | $5.35 | 8,000 | 42,800 | 117,491 | Jan 22, 2025, 06:18 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Jan 21, 2025 | Sale | $86.51 | 8,000 | 692,101 | 112,173 | Jan 22, 2025, 06:18 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Dec 18, 2024 | Option/RSU Exercise | $5.35 | 8,000 | 42,800 | 117,491 | Dec 19, 2024, 04:07 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Dec 18, 2024 | Sale | $88.78 | 8,000 | 710,249 | 116,301 | Dec 19, 2024, 04:07 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Nov 18, 2024 | Option/RSU Exercise | $5.35 | 8,000 | 42,800 | 117,491 | Nov 19, 2024, 04:43 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Nov 18, 2024 | Sale | $85.81 | 8,000 | 686,518 | 111,380 | Nov 19, 2024, 04:43 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Oct 25, 2024 | Option/RSU Exercise | $20.93 | 19,108 | 399,930 | 109,491 | Oct 28, 2024, 05:11 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Oct 18, 2024 | Option/RSU Exercise | $5.35 | 42,000 | 224,700 | 132,383 | Oct 22, 2024, 04:11 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Oct 18, 2024 | Sale | $115.39 | 42,000 | 4,846,508 | 96,269 | Oct 22, 2024, 04:11 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Sep 18, 2024 | Option/RSU Exercise | $5.35 | 8,000 | 42,800 | 98,383 | Sep 19, 2024, 05:48 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Sep 18, 2024 | Sale | $115.94 | 8,000 | 927,551 | 92,898 | Sep 19, 2024, 05:48 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Sep 03, 2024 | Tax Payment (Shares) | $110.15 | 6,337 | 698,021 | 90,383 | Sep 05, 2024, 05:18 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Aug 19, 2024 | Option/RSU Exercise | $5.35 | 8,000 | 42,800 | 104,720 | Aug 20, 2024, 04:49 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Aug 19, 2024 | Sale | $78.58 | 8,000 | 628,650 | 99,726 | Aug 20, 2024, 04:49 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Jul 18, 2024 | Option/RSU Exercise | $5.35 | 8,000 | 42,800 | 104,720 | Jul 22, 2024, 04:03 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Jul 18, 2024 | Sale | $81.17 | 8,000 | 649,325 | 101,625 | Jul 22, 2024, 04:03 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Jun 18, 2024 | Sale | $71.92 | 8,000 | 575,375 | 97,068 | Jun 20, 2024, 08:30 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Jun 18, 2024 | Option/RSU Exercise | $5.35 | 8,000 | 42,800 | 104,720 | Jun 20, 2024, 08:30 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | May 20, 2024 | Option/RSU Exercise | $5.35 | 8,000 | 42,800 | 103,679 | May 22, 2024, 05:03 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | May 20, 2024 | Sale | $74.99 | 8,000 | 599,909 | 100,135 | May 22, 2024, 05:03 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Apr 18, 2024 | Option/RSU Exercise | $5.35 | 8,000 | 42,800 | 103,679 | Apr 22, 2024, 04:42 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Apr 18, 2024 | Sale | $61.27 | 8,000 | 490,199 | 96,055 | Apr 22, 2024, 04:42 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Mar 18, 2024 | Option/RSU Exercise | $5.35 | 8,000 | 42,800 | 103,679 | Mar 20, 2024, 04:29 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Mar 18, 2024 | Sale | $69.02 | 8,000 | 552,144 | 95,915 | Mar 20, 2024, 04:29 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Mar 02, 2024 | Tax Payment (Shares) | $71.55 | 3,795 | 271,532 | 95,679 | Mar 04, 2024, 09:20 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Feb 20, 2024 | Option/RSU Exercise | $5.35 | 8,000 | 42,800 | 87,474 | Feb 22, 2024, 04:30 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Feb 20, 2024 | Sale | $74.53 | 8,000 | 596,232 | 82,565 | Feb 22, 2024, 04:30 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Jan 18, 2024 | Sale | $60.73 | 8,000 | 485,879 | 83,087 | Jan 19, 2024, 04:17 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | PRESIDENT AND CFO | Jan 18, 2024 | Option/RSU Exercise | $5.35 | 8,000 | 42,800 | 87,474 | Jan 19, 2024, 04:17 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Dec 18, 2023 | Option/RSU Exercise | $5.35 | 8,000 | 42,800 | 87,474 | Dec 20, 2023, 04:35 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Dec 18, 2023 | Sale | $60.18 | 8,000 | 481,417 | 79,591 | Dec 20, 2023, 04:35 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Dec 14, 2023 | Option/RSU Exercise | $5.35 | 14,000 | 74,900 | 93,474 | Dec 18, 2023, 04:01 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Dec 14, 2023 | Sale | $60.22 | 14,000 | 843,080 | 79,474 | Dec 18, 2023, 04:01 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Nov 20, 2023 | Option/RSU Exercise | $5.35 | 8,000 | 42,800 | 87,474 | Nov 22, 2023, 04:51 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Nov 20, 2023 | Sale | $51.13 | 8,000 | 409,063 | 79,598 | Nov 22, 2023, 04:51 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Oct 18, 2023 | Option/RSU Exercise | $5.35 | 8,000 | 42,800 | 87,474 | Oct 20, 2023, 04:30 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Oct 18, 2023 | Sale | $45.91 | 8,000 | 367,300 | 79,977 | Oct 20, 2023, 04:30 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Sep 05, 2023 | Tax Payment (Shares) | $51.00 | 3,568 | 181,968 | 79,474 | Sep 06, 2023, 05:34 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Sep 19, 2022 | Option/RSU Exercise | $5.35 | 3,100 | 16,585 | 40,638 | Sep 21, 2022, 06:05 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Sep 19, 2022 | Sale | $26.10 | 3,100 | 80,898 | 38,015 | Sep 21, 2022, 06:05 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Sep 02, 2022 | Tax Payment (Shares) | $26.38 | 4,649 | 122,641 | 37,538 | Sep 07, 2022, 04:33 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Aug 26, 2022 | Sale | $28.00 | 1,295 | 36,260 | 42,187 | Aug 29, 2022, 05:46 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Aug 29, 2022 | Option/RSU Exercise | $5.35 | 17,653 | 94,444 | 59,840 | Aug 29, 2022, 05:46 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Aug 29, 2022 | Sale | $28.00 | 17,653 | 494,284 | 42,187 | Aug 29, 2022, 05:46 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Aug 25, 2022 | Option/RSU Exercise | $5.35 | 17,052 | 91,228 | 59,239 | Aug 29, 2022, 05:46 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Aug 25, 2022 | Sale | $28.00 | 17,052 | 477,456 | 42,187 | Aug 29, 2022, 05:46 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Aug 26, 2022 | Option/RSU Exercise | $5.35 | 1,295 | 6,928 | 43,482 | Aug 29, 2022, 05:46 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Aug 18, 2022 | Option/RSU Exercise | $5.35 | 3,100 | 16,585 | 45,287 | Aug 22, 2022, 04:41 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Aug 18, 2022 | Sale | $25.26 | 3,100 | 78,320 | 42,736 | Aug 22, 2022, 04:41 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Jul 18, 2022 | Option/RSU Exercise | $5.35 | 3,100 | 16,585 | 45,287 | Jul 20, 2022, 05:27 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Jul 18, 2022 | Sale | $24.53 | 3,100 | 76,047 | 42,196 | Jul 20, 2022, 05:27 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Jul 08, 2022 | Option/RSU Exercise | $5.35 | 3,100 | 16,585 | 45,287 | Jul 12, 2022, 05:12 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Jul 08, 2022 | Sale | $24.00 | 3,100 | 74,400 | 42,187 | Jul 12, 2022, 05:12 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | May 18, 2022 | Sale | $24.44 | 3,100 | 75,763 | 42,767 | May 20, 2022, 05:01 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | May 18, 2022 | Option/RSU Exercise | $5.35 | 3,100 | 16,585 | 45,287 | May 20, 2022, 05:01 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Apr 18, 2022 | Option/RSU Exercise | $5.35 | 3,100 | 16,585 | 43,725 | Apr 20, 2022, 04:55 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Apr 18, 2022 | Sale | $24.05 | 3,100 | 74,542 | 40,625 | Apr 20, 2022, 04:55 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Mar 18, 2022 | Option/RSU Exercise | $5.35 | 3,100 | 16,585 | 43,725 | Mar 22, 2022, 04:22 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Mar 18, 2022 | Sale | $26.13 | 3,100 | 80,993 | 40,625 | Mar 22, 2022, 04:22 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Mar 01, 2022 | Sale | $24.00 | 6,200 | 148,800 | 3,125 | Mar 03, 2022, 04:39 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Mar 01, 2022 | Option/RSU Exercise | $5.35 | 6,200 | 33,170 | 9,325 | Mar 03, 2022, 04:39 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Dec 23, 2021 | Option/RSU Exercise | $5.35 | 3,100 | 16,585 | 6,225 | Dec 28, 2021, 04:13 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Dec 23, 2021 | Sale | $24.00 | 3,100 | 74,400 | 3,125 | Dec 28, 2021, 04:13 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Nov 18, 2021 | Option/RSU Exercise | $5.35 | 3,100 | 16,585 | 6,225 | Nov 22, 2021, 04:58 PM | |
| PCVX | Vaxcyte, Inc. | Andrew Guggenhime | President and CFO | Nov 18, 2021 | Sale | $24.53 | 3,100 | 76,031 | 3,240 | Nov 22, 2021, 04:58 PM |
